In addition, we demonstrated that Treg cells from RA patients can suppress proliferation of both CD25− and CD25int Teff cells to a similar extent as healthy control Treg cells, even though CD25int Teff cells contained increased percentages of IL‐17+ and TNF+ cells, suggesting a potentially higher activation status of these cells. This evidence concerns the gene IL17A and rheumatoid arthritis.